Common-Size Income Statement
Quarterly Data

Thermo Fisher Scientific Inc., common-size consolidated income statement (quarterly data)

3 months ended:	Sep 28, 2024	Jun 29, 2024	Mar 30, 2024	Dec 31, 2023	Sep 30, 2023	Jul 1, 2023	Apr 1, 2023	Dec 31, 2022	Oct 1, 2022	Jul 2, 2022	Apr 2, 2022	Dec 31, 2021	Oct 2, 2021	Jul 3, 2021	Apr 3, 2021	Dec 31, 2020	Sep 26, 2020	Jun 27, 2020	Mar 28, 2020	Dec 31, 2019	Sep 28, 2019	Jun 29, 2019	Mar 30, 2019
Product revenues	58.01%	58.47%	57.56%	58.89%	58.23%	58.68%	59.79%	60.66%	61.66%	63.84%	67.84%	74.11%	78.89%	77.80%	79.31%	81.93%	79.59%	75.90%	74.32%	75.43%	76.50%	76.42%	77.06%
Service revenues	41.99%	41.53%	42.44%	41.11%	41.77%	41.32%	40.21%	39.34%	38.34%	36.16%	32.16%	25.89%	21.11%	22.20%	20.69%	18.07%	20.41%	24.10%	25.68%	24.57%	23.50%	23.58%	22.94%
Revenues	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Cost of product revenues	-29.91%	-29.22%	-28.41%	-30.67%	-30.40%	-30.67%	-31.16%	-32.16%	-32.72%	-32.05%	-30.08%	-33.80%	-35.35%	-36.15%	-33.59%	-34.83%	-35.22%	-34.57%	-37.56%	-39.16%	-39.40%	-39.23%	-39.41%
Cost of service revenues	-29.25%	-29.54%	-30.94%	-28.97%	-28.79%	-29.55%	-30.19%	-27.62%	-26.98%	-26.03%	-23.68%	-17.11%	-14.80%	-15.07%	-13.83%	-12.50%	-13.95%	-16.61%	-18.46%	-16.40%	-16.55%	-16.07%	-16.39%
Cost of revenues	-59.16%	-58.76%	-59.35%	-59.65%	-59.18%	-60.22%	-61.34%	-59.77%	-59.71%	-58.08%	-53.77%	-50.91%	-50.15%	-51.21%	-47.42%	-47.34%	-49.17%	-51.18%	-56.02%	-55.56%	-55.95%	-55.30%	-55.80%
Gross profit	40.84%	41.24%	40.65%	40.35%	40.82%	39.78%	38.66%	40.23%	40.29%	41.92%	46.23%	49.09%	49.85%	48.79%	52.58%	52.66%	50.83%	48.82%	43.98%	44.44%	44.05%	44.70%	44.20%
Selling, general and administrative expenses	-19.80%	-20.03%	-21.10%	-19.58%	-19.38%	-20.07%	-19.79%	-20.08%	-20.68%	-20.14%	-19.27%	-21.29%	-21.48%	-20.48%	-18.43%	-19.69%	-18.68%	-24.72%	-24.90%	-22.14%	-24.54%	-24.78%	-24.95%
Research and development expenses	-3.26%	-3.22%	-3.20%	-3.00%	-3.02%	-3.23%	-3.23%	-3.41%	-3.29%	-3.33%	-3.08%	-3.66%	-3.76%	-3.70%	-3.23%	-3.56%	-3.47%	-3.82%	-3.93%	-3.84%	-3.94%	-3.89%	-4.05%
Restructuring and other income (costs)	-0.43%	-0.73%	-0.27%	-0.73%	-0.79%	-1.71%	-1.05%	-0.48%	-0.31%	-0.22%	-0.02%	-0.43%	-0.19%	-1.28%	-0.14%	-0.30%	-0.20%	-0.17%	-0.61%	-0.42%	-0.49%	7.66%	-0.18%
Operating income	17.34%	17.27%	16.08%	17.03%	17.63%	14.77%	14.59%	16.25%	16.02%	18.24%	23.87%	23.72%	24.42%	23.33%	30.78%	29.11%	28.47%	20.11%	14.54%	18.04%	15.08%	23.69%	15.02%
Interest income	2.61%	2.80%	2.70%	2.84%	2.33%	1.67%	1.36%	1.31%	0.64%	0.33%	0.15%	0.10%	0.10%	0.12%	0.12%	0.11%	0.11%	0.12%	0.58%	0.66%	0.83%	0.95%	1.09%
Interest expense	-3.36%	-3.36%	-3.51%	-3.58%	-3.40%	-3.05%	-2.80%	-2.35%	-1.62%	-1.35%	-1.15%	-1.50%	-1.37%	-1.32%	-1.26%	-1.38%	-1.69%	-1.98%	-2.02%	-2.08%	-2.61%	-2.87%	-3.09%
Other income (expense)	-0.16%	0.04%	0.10%	-0.30%	0.13%	0.00%	-0.43%	0.31%	-0.04%	0.26%	-1.38%	-4.91%	0.19%	-0.03%	-1.85%	-0.43%	-0.46%	-0.13%	0.19%	-1.42%	-0.19%	0.28%	0.31%
Income from continuing operations before income taxes	16.44%	16.74%	15.36%	15.98%	16.69%	13.38%	12.73%	15.52%	14.99%	17.47%	21.49%	17.40%	23.33%	22.10%	27.79%	27.41%	26.43%	18.11%	13.29%	15.20%	13.11%	22.06%	13.34%
Provision for income taxes	-0.93%	-1.21%	-2.72%	-1.22%	-0.50%	-0.49%	-0.43%	-1.51%	-0.29%	-1.80%	-2.55%	-1.90%	-2.90%	-2.36%	-4.20%	-3.73%	-3.74%	-1.40%	-0.64%	-0.53%	-0.99%	-4.34%	-0.03%
Equity in earnings (losses) of unconsolidated entities	-0.13%	-0.80%	0.22%	-0.01%	-0.16%	-0.15%	-0.23%	-0.26%	-0.67%	-0.46%	-0.16%	0.00%	-0.03%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net income	15.37%	14.73%	12.87%	14.75%	16.03%	12.74%	12.06%	13.75%	14.03%	15.21%	18.78%	15.50%	20.40%	19.72%	23.59%	23.68%	22.69%	16.71%	12.65%	14.67%	12.12%	17.72%	13.31%
Net (income) losses attributable to noncontrolling interests and redeemable noncontrolling interest	0.01%	-0.05%	-0.03%	0.22%	0.19%	-0.01%	-0.03%	0.02%	-0.03%	-0.04%	-0.04%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net income attributable to Thermo Fisher Scientific Inc.	15.38%	14.69%	12.84%	14.97%	16.22%	12.74%	12.04%	13.76%	14.00%	15.17%	18.74%	15.49%	20.39%	19.71%	23.59%	23.68%	22.69%	16.71%	12.65%	14.67%	12.12%	17.72%	13.31%

Download chart

Income statement item	Description	The company
Operating income	The net result for the period of deducting operating expenses from operating revenues.	Thermo Fisher Scientific Inc. operating income as a percentage of revenues increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Income from continuing operations before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Thermo Fisher Scientific Inc. income from continuing operations before income taxes as a percentage of revenues increased from Q1 2024 to Q2 2024 but then slightly decreased from Q2 2024 to Q3 2024.
Net income attributable to Thermo Fisher Scientific Inc.	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Thermo Fisher Scientific Inc. net income attributable to Thermo Fisher Scientific Inc. as a percentage of revenues increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Thermo Fisher Scientific Inc. (NYSE:TMO)

Common-Size Income Statement Quarterly Data

Common-Size Income Statement
Quarterly Data